Endocrinology, Vol 115, 640-648, Copyright © 1984 by Endocrine Society

ARTICLES

Vitamin D-dependent rat renal calcium-binding protein: development of a radioimmunoassay, tissue distribution, and immunologic identification

J Sonnenberg, AR Pansini and S Christakos

A sensitive double antibody RIA has been developed for the 28,000 mol wt rat renal vitamin D-dependent calcium-binding protein. Using this assay, concentrations of calcium-binding protein (CaBP) as low as 30 ng can be measured. The assay is precise (intraassay variability, 5.0%) and reproductible (interassay variability, 8.2%). Measurements of renal CaBP by RIA showed a good correlation with measurements of CaBP by the chelex resin assay and by polyacrylamide gel analysis by densitometric tracing using a purified CaBP marker. The concentration of CaBP in the vitamin D-replete rat kidney is 7.3 +/- 1.0 (mean +/- SEM) micrograms/mg protein. In vitamin D-deficient rats the level of renal CaBP is 2.6 +/- 0.3 micrograms/mg protein. Tissue distribution of immunoreactive rat renal CaBP showed the highest concentration of CaBP in the rat cerebellum (38.3 +/- 5.1 micrograms/mg protein). Lower concentrations of immunoreactive CaBP were detected in several other rat tissues. No immunoreactive CaBP was detected in rat or human serum. In necropsy human kidney and cerebellum, high levels of immunoreactive CaBP were also detected (1.5 +/- 0.1 and 27.3 +/- 2.1 micrograms/mg protein, respectively). When extracts of rat kidney and brain and human cerebellum and kidney were assayed at several dilutions, immunodisplacement curves parallel to that of pure renal CaBP were observed, indicating immunochemical similarity. Fractionation of extracts of rat cerebellum, human kidney, and human cerebellum on Sephadex G-100 revealed immunoreactivity and calcium-binding activity in the 28,000 mol wt region similar to rat kidney.

This article has been cited by other articles:

				A. Rabinovitch, W. L. Suarez-Pinzon, K. Sooy, K. Strynadka, and S. Christakos Expression of Calbindin-D28k in a Pancreatic Islet {beta}-Cell Line Protects against Cytokine-Induced Apoptosis and Necrosis Endocrinology, August 1, 2001; 142(8): 3649 - 3655. [Abstract] [Full Text] [PDF]

				K. Sooy, T. Schermerhorn, M. Noda, M. Surana, W. B. Rhoten, M. Meyer, N. Fleischer, G. W. G. Sharp, and S. Christakos Calbindin-D28k Controls [Ca2+]i and Insulin Release. EVIDENCE OBTAINED FROM CALBINDIN-D28k KNOCKOUT MICE AND beta CELL LINES J. Biol. Chem., November 26, 1999; 274(48): 34343 - 34349. [Abstract] [Full Text] [PDF]

				D. Reddy, A. S. Pollock, S. A. Clark, K. Sooy, R. C. Vasavada, A. F. Stewart, T. Honeyman, and S. Christakos Transfection and overexpression of the calcium binding protein calbindin-D28k results in a stimulatory effect on insulin synthesis in a rat beta  cell line (RIN 1046-38) PNAS, March 4, 1997; 94(5): 1961 - 1966. [Abstract] [Full Text] [PDF]

				A. S. Pollock and H. L. Santiesteban Calbindin Expression in Renal Tubular Epithelial Cells J. Biol. Chem., July 7, 1995; 270(27): 16291 - 16301. [Abstract] [Full Text] [PDF]

				T. Bellido, M. Huening, M. Raval-Pandya, S. C. Manolagas, and S. Christakos Calbindin-D28k Is Expressed in Osteoblastic Cells and Suppresses Their Apoptosis by Inhibiting Caspase-3 Activity J. Biol. Chem., August 18, 2000; 275(34): 26328 - 26332. [Abstract] [Full Text] [PDF]